Page last updated: 2024-08-17

colchicine and Disease Exacerbation

colchicine has been researched along with Disease Exacerbation in 60 studies

Research

Studies (60)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (6.67)18.2507
2000's18 (30.00)29.6817
2010's25 (41.67)24.3611
2020's13 (21.67)2.80

Authors

AuthorsStudies
Berkun, Y; Biro, O; Dor-Wollman, T; Eisenstein, EM; Gileles-Hillel, A1
Alogna, A; El-Shafeey, M; Elsanhoury, A; Fechner, H; Kühl, U; Lin, J; Pappritz, K; Schulz, R; Spillmann, F; Tschöpe, C; Van Linthout, S1
Avanoglu Guler, A; Bilici, R; Coskun, C; Goker, B; Haznedaroglu, S; Karadeniz, H; Kasifoglu, T; Kucuk, H; Ozturk, MA; Sari, I; Satis, H; Tufan, A; Yildirim, D; Yuce Inel, T1
Ali, Z; Anand, SS; Avezum, A; Bangdiwala, SI; Belley-Cote, EP; Berwanger, O; Bosch, J; Choudhri, S; Dans, AL; Eikelboom, JW; Farkouh, ME; Felix, C; Harper, W; Hassany, M; Heenan, L; Jolly, SS; Kontsevaya, A; Loeb, M; Lopes, RD; Lopez-Jaramillo, P; Pais, P; Palileo-Villanueva, LM; Rangarajan, S; Sharma, SK; Tarhuni, WM; Wasserman, S; Whitlock, RP; Xavier, D; Xu, L; Yusuf, S; Yusufali, A1
Almas, A; Anand, SS; Avezum, A; Bangdiwala, SI; Belley-Cote, EP; Berwanger, O; Bosch, J; Choudhri, S; Diaz, R; Drapkina, O; Eikelboom, JW; Farkouh, ME; Felix, C; Harper, W; Hassany, M; Heenan, L; Jolly, SS; Kumar Sharma, S; Loeb, M; Lopes, RD; Lopez-Jaramillo, P; Luz Diaz, M; Rangarajan, S; Tarhuni, WM; Wasserman, S; Whitlock, RP; Xu, L; Yusuf, S; Yusufali, A1
Aktaş, İ; Altıntaş Meşe, C; Çakan, M; Otar Yener, G1
Schectman, JM1
Cornel, JH; Eikelboom, JW; Fiolet, ATL; Heijman, MWJ; Mosterd, A; Nidorf, SM; Popa, CD; Schut, A; Thompson, PL; Tijssen, JGP; van den Bemt, BJF; van den Ende, CHM1
Armagan, B; Atas, N; Babaoglu, H; Bilge, NSY; Bodakci, E; Goker, B; Haznedaroglu, S; Kalyoncu, U; Kasifoglu, T; Kilic, L; Ozturk, MA; Salman, RB; Sari, A; Satis, H; Tufan, A; Yardımcı, GK1
Barbas, C; Cecconi, A; Godzien, J; Ibañez, B; Izidoro, MA; López-Gonzálvez, Á; Mateo, J; Panadero, MI; Ruiz-Cabello, J; Rupérez, FJ; Vilchez, JP1
Dalbeth, N; Donovan, P; Robinson, PC1
Alexopoulos, D; Angelidis, C; Baltagiannis, S; Cleman, M; Dangas, G; Davlouros, P; Deftereos, SG; Dolianitis, K; Gargalianos, P; Gerakari, S; Giannopoulos, G; Giotaki, SG; Gogos, C; Goudevenos, J; Hahalis, G; Iliodromitis, E; Kanonidis, I; Katritsis, D; Kolettis, T; Kotanidou, A; Koulouris, NG; Manolis, AS; Martinèz-Dolz, L; Mehran, R; Metallidis, S; Michalis, L; Migdalis, I; Milionis, H; Naka, KK; Olympios, CD; Panagopoulos, P; Pyrgakis, VN; Randou, E; Reimers, B; Sianos, G; Siasos, GD; Sipsas, N; Stefanadis, C; Stefanini, GG; Syrigos, K; Tousoulis, D; Toutouzas, KP; Triposkiadis, F; Tsagalou, E; Tsiodras, S; Tsioufis, K; Tsoukalas, G; Vavouranakis, E; Vrachatis, DA1
Ahmadi, M; Askari, VR; Baradaran Rahimi, V; Gholoobi, A; Naghedinia, H; Vakili, V1
Chakraborty, B; Chowbay, B; Haaland, B; Huebner, JL; Kraus, VB; Leung, YY; Tan, MH; Thumboo, J; Tjai, M; Wang, C; Wong, SBS1
Amarilyo, G; Brik, R; Butbul-Aviel, Y; Hezkelo, N; Uziel, Y1
Abbade, LPF; Ferreira, ER; Lima, TRR; Miola, AC; Miot, HA; Schmitt, JV1
Bonetto, V; Carra, S; Cereda, C; Ceroni, M; Chio, A; Crippa, V; D'Agostino, VG; D'Amico, R; Gessani, A; Mandrioli, J; Monsurrò, MR; Poletti, A; Provenzani, A; Riva, N; Sabatelli, M; Silani, V; Simone, IL; Sorarù, G; Zucchi, E1
Jamil, H; Khawla, K; Moez, J; Raida, BS; Saida, G; Sameh, M; Yosra, C; Zouhir, B1
Eikelboom, JW; Nidorf, SM; Thompson, PL1
Ching, JK; Ju, JS; Margeta, M; Pittman, SK; Weihl, CC1
Cheetham, TC; Levy, GD; Niu, F; Rashid, N1
Federman, DG; Galen, BT1
Aubert, JP; Delva, C; Ea, HK; Guggenbuhl, P; Lambert, C; Lancrenon, S; Lanz, S; Lioté, F; Pascart, T; Saraux, A1
Ben-Chetrit, E; Hayrapetyan, H; Sarkisian, T; Shahsuvaryan, G1
Matsuyoshi, T1
Bonilla-Abadía, F; Cañas, CA; Suso, JP; Tobón, GJ; Vernaza-Pizarro, A; Zuñiga-Velásquez, A1
Han, SJ; Kim, JH; Kim, JI; Park, KM1
Basso, D; Burlando, M; Cimmino, MA; Cozzani, E; Drago, F; Larosa, M; Parodi, A; Rongioletti, F1
Stamp, LK1
Agarwal, GG; Asthana, A; Das, SK; Goel, G; Srivastava, R1
Asial, R; Boente, Mdel C; Happle, R; Nadra, G1
Basturk, T; Kusaslan, R; Ozagari, A; Ozturk, T; Unsal, A1
Bonder, A; Bonis, PA; Kaplan, MM; Ruthazer, R1
Graser, E; Pope, RS; Zychowicz, ME1
El-Zawawy, H; Mandell, BF1
Kojima, N; Misawa, Y; Ohki, S; Sakano, Y1
Cacoub, P; Geri, G1
Aktas, A; Engin, RI; Eren, YB; Karakuzu, A; Karatay, S; Kiziltunc, A; Yildirim, K1
Livneh, A1
Elhan, AH; Erdogan, BD; Özçakar, ZB; Yalçinkaya, F1
Ates, K; Civriz, S; Ensari, A; Karatan, O; Kutlay, S; Nergizoglu, G1
Kaymak, B; Köklü, S; Kuran, S; Ozçakar, L; Sakaoğullari, Z1
Angulo, P; Lindor, KD1
Kalunian, KC; Wu, CW1
Pouchot, J; Vinceneux, P1
Froment, R; Radisic, M; Santamarina, J1
Cottin, V1
Basugi, A; Ikusaka, M; Itoga, S; Kim, S; Mikasa, G; Nishizawa, S; Nomura, F; Ohira, Y; Sunaga, M1
Apak, H; Arisoy, N; Bilgen, H; Celkan, T; Demirel, A; Kasapcopur, O; Ozkan, A; Yildiz, I1
Brownell, I; Franks, AG; Soter, NA1
Announ, N; Guerne, PA1
Chen, GS; Lan, CC; Lu, YW; Tsai, J; Wu, CS1
Dinarello, CA; Kaplan, MM; McKusick, AF; Miller, LC; Sharma, A; Tassoni, JP1
el Nahas, AM; Zhang, G1
Kaplan, MM1
Rockey, DC1
Fradin, Z; Mittelman, M; Sender, BZ; Yarmolovsky, A; Zeidman, A1
Aksentijevich, I; Kastner, DL; Koziol, DE; Langevitz, P; Livneh, A; Pras, E; Pras, M; Shinar, Y; Zaks, N1
Karagezian, KG; Nazaretian, EE; Ovnanian, KO; Zavrodniaia, AM1
Ben Ghorbel, I; Feki, M; Houman, H; Khanfir, M; Lamloum, M; Mebazaa, A; Miled, M1

Reviews

11 review(s) available for colchicine and Disease Exacerbation

ArticleYear
Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.
    Journal of cardiovascular pharmacology and therapeutics, 2014, Volume: 19, Issue:1

    Topics: Animals; Cardiovascular Diseases; Cholesterol; Colchicine; Crystallization; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Macrophages; Molecular Targeted Therapy; Neutrophils; Plaque, Atherosclerotic; Secondary Prevention

2014
Major unanswered questions in the clinical gout field.
    Current opinion in rheumatology, 2017, Volume: 29, Issue:2

    Topics: Allopurinol; Benzbromarone; Colchicine; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Patient Care Planning; Probenecid; Renal Insufficiency, Chronic; Uric Acid; Uricosuric Agents

2017
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
    Journal of renal care, 2009, Volume: 35, Issue:3

    Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colchicine; Crohn Disease; Disease Progression; Early Diagnosis; Humans; Hypertension; Hypoalbuminemia; Kidney Failure, Chronic; Male; Mesalamine; Proteinuria; Rare Diseases; Renal Dialysis; Risk Factors; Time Factors

2009
Managing gout: how is it different in patients with chronic kidney disease?
    Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:12

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Kidney Failure, Chronic; Risk Factors; Thiazoles

2010
[What's new in recurrent pericarditis in 2011?].
    La Revue de medecine interne, 2011, Volume: 32, Issue:12

    Topics: Acute Disease; Algorithms; Aspirin; Colchicine; Disease Progression; Humans; Pericarditis; Recurrence; Standard of Care

2011
Management of primary biliary cirrhosis and autoimmune cholangitis.
    Clinics in liver disease, 1998, Volume: 2, Issue:2

    Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Cholangitis; Colchicine; Disease Progression; Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Penicillamine; Ursodeoxycholic Acid

1998
New developments in osteoarthritis.
    Clinics in geriatric medicine, 2005, Volume: 21, Issue:3

    Topics: Acetaminophen; Acupuncture Therapy; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Chondroitin; Colchicine; Disease Progression; Glucosamine; Gout Suppressants; Humans; Osteoarthritis; Radiography; Synovial Membrane

2005
[From familial Mediterranean fever to amyloidosis].
    Presse medicale (Paris, France : 1983), 2005, Jul-23, Volume: 34, Issue:13

    Topics: Acute Disease; Amyloidosis; Colchicine; Disease Progression; Familial Mediterranean Fever; Gout Suppressants; Humans; Prognosis

2005
[Idiopathic interstitial pneumonia: treatment].
    Revue des maladies respiratoires, 2006, Volume: 23, Issue:4 Pt 2

    Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benzamides; Bronchiolitis Obliterans; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colchicine; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunologic Factors; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sex Factors

2006
The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
    Seminars in liver disease, 1997, Volume: 17, Issue:2

    Topics: Adjuvants, Immunologic; Cholagogues and Choleretics; Colchicine; Disease Progression; Drug Therapy, Combination; Female; Gout Suppressants; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Methotrexate; Ursodeoxycholic Acid

1997
Hepatic fibrogenesis and hepatitis C.
    Seminars in gastrointestinal disease, 2000, Volume: 11, Issue:2

    Topics: Adrenal Cortex Hormones; Animals; Biopsy; Cells, Cultured; Colchicine; Disease Progression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; Retinoids

2000

Trials

10 trial(s) available for colchicine and Disease Exacerbation

ArticleYear
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
    The Lancet. Respiratory medicine, 2022, Volume: 10, Issue:12

    Topics: Aspirin; Canada; Colchicine; COVID-19; Disease Progression; Humans; SARS-CoV-2; Thrombosis; Treatment Outcome

2022
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
    The Lancet. Respiratory medicine, 2022, Volume: 10, Issue:12

    Topics: Adolescent; Adult; Aspirin; Canada; Colchicine; COVID-19 Drug Treatment; Disease Progression; Humans; Oxygen; Rivaroxaban; Treatment Outcome

2022
In high-risk outpatients with COVID-19, neither colchicine nor aspirin reduced disease progression or death at 45 d.
    Annals of internal medicine, 2023, Volume: 176, Issue:2

    Topics: Aspirin; Colchicine; COVID-19; Disease Progression; Humans; Outpatients; Treatment Outcome

2023
Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements : Exploratory Analyses From a Randomized, Controlled, Double-Blind Trial.
    Annals of internal medicine, 2023, Volume: 176, Issue:6

    Topics: Arthroplasty, Replacement, Hip; Australia; Colchicine; Disease Progression; Double-Blind Method; Humans; Incidence; Osteoarthritis; Osteoarthritis, Knee

2023
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
    JAMA network open, 2020, 06-01, Volume: 3, Issue:6

    Topics: Aged; Aged, 80 and over; Betacoronavirus; C-Reactive Protein; Cause of Death; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diarrhea; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Greece; Hospitalization; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Time Factors; Treatment Outcome; Troponin; Tubulin Modulators

2020
Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial.
    Inflammopharmacology, 2021, Volume: 29, Issue:5

    Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Colchicine; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Non-ST Elevated Myocardial Infarction

2021
Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial.
    Osteoarthritis and cartilage, 2018, Volume: 26, Issue:5

    Topics: Administration, Oral; Adult; Aged; Biomarkers; Colchicine; Cytokines; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Inflammation; Male; Middle Aged; Osteoarthritis, Knee; Synovial Fluid; Treatment Outcome; Young Adult

2018
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
    The British journal of dermatology, 2018, Volume: 179, Issue:5

    Topics: Aged; Aminolevulinic Acid; Atrophy; Biopsy; Carcinoma, Squamous Cell; Colchicine; Disease Progression; Female; Forearm; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays

2018
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
    BMJ open, 2019, 05-30, Volume: 9, Issue:5

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Autophagy; Biomarkers; Clinical Trials, Phase II as Topic; Colchicine; Disease Progression; DNA-Binding Proteins; Double-Blind Method; Female; Heat-Shock Proteins; HSP20 Heat-Shock Proteins; Humans; Male; Middle Aged; Molecular Chaperones; Motor Neurons; Neuroprotective Agents; Proteostasis; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult

2019
Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
    Hepatology (Baltimore, Md.), 1995, Volume: 22, Issue:2

    Topics: Adult; Aged; Alkaline Phosphatase; Bilirubin; Colchicine; Disease Progression; Double-Blind Method; Female; Humans; Interleukin-1; Leukocyte Count; Leukocytes, Mononuclear; Liver; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Staphylococcus epidermidis

1995

Other Studies

39 other study(ies) available for colchicine and Disease Exacerbation

ArticleYear
Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings.
    European journal of pediatrics, 2022, Volume: 181, Issue:3

    Topics: Adolescent; Child; Colchicine; Disease Progression; Familial Mediterranean Fever; Fever; Humans; Pyrin; Siblings; Surveys and Questionnaires

2022
Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis.
    ESC heart failure, 2022, Volume: 9, Issue:2

    Topics: Animals; Colchicine; Disease Progression; Humans; Inflammasomes; Mice; Myocarditis; NLR Family, Pyrin Domain-Containing 3 Protein

2022
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease.
    Modern rheumatology, 2023, Jul-04, Volume: 33, Issue:4

    Topics: Arthritis; Colchicine; COVID-19; Disease Progression; Familial Mediterranean Fever; Female; Fever; Humans; Male

2023
Does having MEFV gene sequence variants affect the clinical course and colchicine response in children with PFAPA syndrome?
    European journal of pediatrics, 2023, Volume: 182, Issue:1

    Topics: Adrenal Cortex Hormones; Child; Colchicine; Disease Progression; Familial Mediterranean Fever; Fever; Humans; Lymphadenitis; Lymphadenopathy; Pharyngitis; Pyrin; Retrospective Studies; Stomatitis, Aphthous

2023
Familial Mediterranean fever-associated infertility and underlying factors.
    Clinical rheumatology, 2020, Volume: 39, Issue:1

    Topics: Adult; Colchicine; Disease Progression; Familial Mediterranean Fever; Female; Genotype; Homozygote; Humans; Infertility; Logistic Models; Male; Middle Aged; Mutation; Pyrin; Risk Factors; Severity of Illness Index; Turkey

2020
Plasma Metabolic Signature of Atherosclerosis Progression and Colchicine Treatment in Rabbits.
    Scientific reports, 2020, 04-27, Volume: 10, Issue:1

    Topics: Animals; Atherosclerosis; Colchicine; Dietary Fats; Disease Models, Animal; Disease Progression; Humans; Metabolomics; Rabbits; Random Allocation

2020
Cost-Effectiveness of Colchicine Prophylaxis for Gout Flares When Commencing Allopurinol.
    Arthritis care & research, 2021, Volume: 73, Issue:10

    Topics: Allopurinol; Australia; Colchicine; Cost-Benefit Analysis; Disease Progression; Drug Costs; Gout; Gout Suppressants; Humans; Quality-Adjusted Life Years; Time Factors; Treatment Outcome; United States

2021
Is palindromic rheumatism amongst children a benign disease?
    Pediatric rheumatology online journal, 2018, Feb-13, Volume: 16, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Arthritis, Rheumatoid; Child; Child, Preschool; Colchicine; Cross-Sectional Studies; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Israel; Male; Retrospective Studies

2018
[Renal amyloidosis complicating adult onset Still's disease: about three cases].
    The Pan African medical journal, 2019, Volume: 32

    Topics: Adrenal Cortex Hormones; Adult; Amyloidosis; Biopsy, Needle; Colchicine; Disease Progression; Female; Humans; Kidney Failure, Chronic; Methotrexate; Middle Aged; Nephrotic Syndrome; Renal Insufficiency; Still's Disease, Adult-Onset

2019
Increased autophagy accelerates colchicine-induced muscle toxicity.
    Autophagy, 2013, Volume: 9, Issue:12

    Topics: Animals; Autophagy; Colchicine; Disease Progression; Humans; Lysosomal Storage Diseases; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Diseases; Phagosomes; Simvastatin; Up-Regulation; Vacuoles

2013
Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia.
    The Journal of rheumatology, 2014, Volume: 41, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Databases, Factual; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Proportional Hazards Models; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Uric Acid

2014
Large tophi and nodal arthritis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:6

    Topics: Aged; Allopurinol; Colchicine; Comorbidity; Disease Progression; Gout; Gout Suppressants; Hand Joints; Humans; Male; Osteoarthritis; Rheumatic Nodule

2014
GOSPEL 2 - Colchicine for the treatment of gout flares in France - a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age.
    Joint bone spine, 2016, Volume: 83, Issue:6

    Topics: Age Factors; Aged; Colchicine; Cross-Sectional Studies; Disease Management; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; France; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Kidney Function Tests; Male; Maximum Tolerated Dose; Middle Aged; Patient Safety; Practice Guidelines as Topic; Practice Patterns, Physicians'; Risk Assessment; Severity of Illness Index; Treatment Outcome

2016
Is plasmapheresis a potential treatment for familial Mediterranean fever patients resistant or intolerant to colchicine?
    International journal of rheumatic diseases, 2017, Volume: 20, Issue:12

    Topics: Adolescent; Colchicine; Disease Progression; Drug Resistance; Familial Mediterranean Fever; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasmapheresis; Treatment Outcome

2017
[A case of colchicine overdose progressing to death rapidly].
    Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology, 2015, Volume: 28, Issue:4

    Topics: Adult; Behcet Syndrome; Bipolar Disorder; Colchicine; Disease Progression; Drug Overdose; Fatal Outcome; Female; Humans; Suicide; Time Factors

2015
Severe deformans tophaceous gouty arthritis.
    Joint bone spine, 2017, Volume: 84, Issue:2

    Topics: Allopurinol; Arthritis, Gouty; Colchicine; Disease Progression; Hand; Humans; Joint Deformities, Acquired; Male; Middle Aged; Prognosis; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Failure

2017
Inhibition of microtubule dynamics impedes repair of kidney ischemia/reperfusion injury and increases fibrosis.
    Scientific reports, 2016, 06-08, Volume: 6

    Topics: Acetylation; Animals; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 2; Colchicine; Disease Progression; Epithelial Cells; Fibrosis; Kidney; Macrophages; Male; Mice; Microtubules; Monocytes; Paclitaxel; Phosphorylation; RAW 264.7 Cells; Reperfusion Injury; Tubulin; Wound Healing

2016
Generalized annular granuloma associated with crowned dens syndrome, which resolved with colchicine treatment.
    Clinical and experimental dermatology, 2016, Volume: 41, Issue:6

    Topics: Chondrocalcinosis; Colchicine; Disease Progression; Female; Gout Suppressants; Granuloma; Granuloma Annulare; Humans; Middle Aged; Neck Pain; Skin Diseases; Synovial Fluid; Tomography, X-Ray Computed; Treatment Outcome

2016
Does long term colchicine prevent degradation of collagen fiber network in osteoarthritis?
    International journal of rheumatic diseases, 2018, Volume: 21, Issue:1

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Antirheumatic Agents; Biomarkers; Cartilage Oligomeric Matrix Protein; Colchicine; Disease Progression; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Fibrillar Collagens; Humans; Osteoarthritis; Proteolysis; Time Factors; Treatment Outcome

2018
Pronounced linear calcinosis in a boy with mild dermatomyositis. A further possible example of superimposed segmental manifestation of a polygenic disorder.
    Dermatology (Basel, Switzerland), 2009, Volume: 219, Issue:2

    Topics: Biopsy, Needle; Calcinosis; Child; Colchicine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Hydroxychloroquine; Immunohistochemistry; Male; Risk Assessment; Severity of Illness Index; Skin Diseases, Genetic; Treatment Outcome

2009
Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:11

    Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Colchicine; Disease Progression; Drug Therapy, Combination; Fibrosis; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Methotrexate; Treatment Failure; Ursodeoxycholic Acid

2010
The current state of care in gout: Addressing the need for better understanding of an ancient disease.
    Journal of the American Academy of Nurse Practitioners, 2010, Volume: 22 Suppl 1

    Topics: Acute Disease; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Chronic Disease; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Patient Education as Topic; Quality of Life; Risk Factors; Thiazoles; Uric Acid; Uricosuric Agents; Xanthine Oxidase

2010
Rapidly growing aortic arch aneurysm in Behcet's disease.
    Interactive cardiovascular and thoracic surgery, 2011, Volume: 12, Issue:3

    Topics: Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Thoracic; Aortography; Behcet Syndrome; Blood Vessel Prosthesis Implantation; Colchicine; Disease Progression; Humans; Male; Middle Aged; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2011
Vitamin D status in patients with Behcet's Disease.
    Clinics (Sao Paulo, Brazil), 2011, Volume: 66, Issue:5

    Topics: Adolescent; Adult; Alkaline Phosphatase; Behcet Syndrome; Biomarkers; Blood Sedimentation; C-Reactive Protein; Calcium; Case-Control Studies; Colchicine; Disease Progression; Female; Humans; Male; Middle Aged; Phosphates; Vitamin D; Young Adult

2011
Diagnosis. Severity scoring system for paediatric FMF.
    Nature reviews. Rheumatology, 2012, Apr-17, Volume: 8, Issue:6

    Topics: Age of Onset; Child; Child, Preschool; Colchicine; Comorbidity; Disease Progression; Erysipelas; Familial Mediterranean Fever; Humans; Pleurisy; Prognosis; Severity of Illness Index

2012
Familial Mediterranean fever in siblings.
    The Journal of rheumatology, 2012, Volume: 39, Issue:11

    Topics: Adolescent; Amyloidosis; Child; Child, Preschool; Colchicine; Cytoskeletal Proteins; Disease Progression; Dose-Response Relationship, Drug; Familial Mediterranean Fever; Female; Humans; Incidence; Infant; Male; Mutation; Pyrin; Risk Factors; Severity of Illness Index; Siblings; Time Factors; Young Adult

2012
Development of amyloidosis in Behçet's syndrome with isolated mucocutaneous involvement.
    Rheumatology international, 2004, Volume: 24, Issue:1

    Topics: Adult; Amyloidosis; Behcet Syndrome; Biopsy; Colchicine; Disease Progression; Humans; Kidney; Male; Mucous Membrane; Prognosis; Sex Factors; Skin; Treatment Outcome

2004
The burden of amyloidosis on the gastrointestinal tract of an ankylosing spondylitis patient.
    Clinical rheumatology, 2003, Volume: 22, Issue:6

    Topics: Adult; Amyloidosis; Biopsy, Needle; Colchicine; Colonoscopy; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Gastrointestinal Diseases; Humans; Immunohistochemistry; Male; Melphalan; Risk Assessment; Spondylitis, Ankylosing

2003
Sustained, progressive, nonresolving abdominal pain: a previously undescribed clinical presentation of familial Mediterranean fever.
    Clinical rheumatology, 2006, Volume: 25, Issue:6

    Topics: Abdominal Pain; Acute-Phase Proteins; Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Disease Progression; Familial Mediterranean Fever; Fever; Humans; Male; Retreatment; Treatment Failure; Treatment Outcome

2006
Clinical study of 7 cases of familial Mediterranean fever with MEFV gene mutation.
    Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:5

    Topics: Abdominal Pain; Adult; Base Sequence; C-Reactive Protein; Chest Pain; Colchicine; Cytoskeletal Proteins; Disease Progression; Drug Administration Schedule; Familial Mediterranean Fever; Female; Humans; Leukocytosis; Male; Middle Aged; Mutation; Pleural Effusion; Pyrin; Radiography, Thoracic; Tomography, X-Ray Computed

2007
Is Familial Mediterranean Fever a thrombotic disease or not?
    European journal of pediatrics, 2008, Volume: 167, Issue:3

    Topics: Adolescent; Adult; Analysis of Variance; Biomarkers; Case-Control Studies; Child; Child, Preschool; Colchicine; Disease Progression; Familial Mediterranean Fever; Female; Humans; Infant; Male; Severity of Illness Index; Statistics, Nonparametric; Thrombosis

2008
Familial linear scleroderma (en coup de sabre) responsive to antimalarials and narrowband ultraviolet B therapy.
    Dermatology online journal, 2007, Jan-27, Volume: 13, Issue:1

    Topics: Adult; Antimalarials; Chloroquine; Colchicine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Forehead; Genetic Predisposition to Disease; Gout Suppressants; Humans; Scleroderma, Localized; Ultraviolet Therapy

2007
[Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].
    Zeitschrift fur Rheumatologie, 2007, Volume: 66, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Calcium Pyrophosphate; Cartilage, Articular; Chondrocalcinosis; Colchicine; Diagnosis, Differential; Disease Progression; Glucocorticoids; Gout Suppressants; Humans; Injections, Intra-Articular; Interleukin-1beta; Methotrexate; Middle Aged; Risk Factors; Synovial Membrane

2007
Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Age of Onset; Behcet Syndrome; Colchicine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; Severity of Illness Index; Taiwan; Treatment Outcome; Uveitis

2008
Colchicine and the progression of experimental renal fibrosis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:3

    Topics: Animals; Colchicine; Disease Progression; Fibrosis; Glomerulosclerosis, Focal Segmental; Gout Suppressants; Kidney; Kidney Failure, Chronic; Male; Rats; Rats, Wistar

1996
Severe amyloidosis with mild multiple myeloma--an unusual course.
    Haematologia, 2000, Volume: 30, Issue:1

    Topics: Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Colchicine; Disease Progression; Fatal Outcome; Female; Heart Failure; Humans; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Prednisone

2000
Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever.
    The Journal of rheumatology, 2000, Volume: 27, Issue:7

    Topics: Age of Onset; Colchicine; Disease Progression; Familial Mediterranean Fever; Female; Genotype; Humans; Male; Phenotype; Sex Factors

2000
[Immunological indices in development of periodic disease].
    Terapevticheskii arkhiv, 2000, Volume: 72, Issue:10

    Topics: Adolescent; Adult; Colchicine; Disease Progression; Familial Mediterranean Fever; Female; Gout Suppressants; Humans; Immunity, Cellular; Lymphocyte Activation; Male; Middle Aged; Prognosis; T-Lymphocytes

2000
Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity.
    Annales de medecine interne, 2001, Volume: 152, Issue:3

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Behcet Syndrome; Case-Control Studies; Colchicine; Disease Progression; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prednisone; Prolactin; Reference Values; Severity of Illness Index; Time Factors

2001